Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001626199-23-000138
Filing Date
2023-12-19
Accepted
2023-12-19 19:50:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5360
  Complete submission text file 0001626199-23-000138.txt   7016
Mailing Address ALPINE IMMUNE SCIENCES, INC. 188 EAST BLAINE STREET, SUITE 200 SEATTLE WA 98102
Business Address
GOLD MITCHELL (Reporting) CIK: 0001242882 (see all company filings)

Type: 144

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37449 | Film No.: 231499033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)